Actinium Pharmaceuticals Inc (Delaware) — Cash Flow (NYSE:ATNM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -21.62 M-20.87 M8.64 M-47.34 M-33.07 M-24.58 M -24.58 M Cash from investing activities -253 K-133 K-366 K-153 K-11 K-104 K 104 K Cash from financing activities 76.18 M35.22 M23.11 M14.87 M29.32 M-217 K -217 K Free cash flow -21.87 M-21 M8.28 M-47.49 M-33.08 M-24.68 M -24.68 M

News

Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?

Actinium Pharmaceuticals stock rises after promising breast cancer therapy data

Actinium’s breast cancer therapy shows promise in preclinical studies

Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?

Actinium’s ATNM-400 shows efficacy in resistant breast cancers

Actinium Pharmaceuticals elects directors and approves proposals at annual meeting

Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?

Actinium’s ATNM-400 shows superior efficacy against lung cancer

Actinium’s ATNM-400 shows promising results in prostate cancer models

Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?

Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?

Actinium’s prostate cancer therapy shows promise against resistant tumors